Arnon Rosenthal

Rosenthal in 2018 Arnon Rosenthal () is an Israeli-American neuroscientist, inventor, and biotechnology entrepreneur.

Rosenthal is an inventor and developer of the pain medicine tanezumab, the migraine medicine fremanezumab, the Alzehimer's drug ponezumab and the target for the basal cell carcinoma medicine vismodegib. Rosenthal founded the biotechnology companies Rinat Neuroscience Corporation in 2001 (acquired by Pfizer in 2006); Annexon, which develops anti-complement medicines for autoimmune neuropathies and degenerative eye diseases, in 2011; and Alector, which develops innate immune (neuroimmunology) drugs for dementia and neurodegeneration, in 2013. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Arnon Rosenthal', query time: 0.02s Refine Results
  1. 1
    Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer’s disease

    Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer’s disease by Balasubrahmanyam Budda, Ananya Mitra, Lovingly Park, Hua Long, Michael Kurnellas, Nga Bien-Ly, William Estacio, Brady Burgess, Grace Chao, Tina Schwabe, Robert Paul, Sara Kenkare-Mitra, Arnon Rosenthal

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease

    Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease by Hua Long, Adam Simmons, Arthur Mayorga, Brady Burgess, Tuan Nguyen, Balasubrahmanyam Budda, Anna Rychkova, Herve Rhinn, Ilaria Tassi, Michael Ward, Felix Yeh, Tina Schwabe, Robert Paul, Sara Kenkare-Mitra, Arnon Rosenthal

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: